Skip to main content

Your privacy choices

We use cookies for necessary site functions and — only with your consent — for analytics and advertising. You can accept all, keep only what's necessary, or choose per category.

Cookie categories
Skip to content

Science

Microbiome startups respond as industry is accused of ‘questionable practices’

The biotech sector has embraced the microbiome in recent years, a green field market powered by cheap genome sequencing and venture dollars, promising bespoke treatments for everything from gut troubles to skin problems. But a report in…

1 min read
XFacebookLinkedIn

The biotech sector has embraced the microbiome in recent years, a green field market powered by cheap genome sequencing and venture dollars, promising bespoke treatments for everything from gut troubles to skin problems. But a report in Science alleges that these companies lack scientific rigor and meaningful regulation, offering little more than guesswork on a […] © 2024 TechCrunch. All rights reserved. For personal use only.

Related stories